Amphastar Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03209R1032

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Rong Zhou. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Rong Zhou har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AMPH / Amphastar Pharmaceuticals, Inc. SENIOR EVP, PRODUCTION CENTER 137.497
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Rong Zhou. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AMPH / Amphastar Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMPH / Amphastar Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
Insidersalg AMPH / Amphastar Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMPH / Amphastar Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-12-13 AMPH Zhou Rong 8.000 45,2300 8.000 45,2300 361.840 217 20.6200 -196.880 -54,41
2024-12-12 AMPH Zhou Rong 7.000 44,4250 7.000 44,4250 310.975
2024-11-12 AMPH Zhou Rong 6.893 48,8800 6.893 48,8800 336.930
2024-09-13 AMPH Zhou Rong 3.000 48,2615 3.000 48,2615 144.784
2024-08-26 AMPH Zhou Rong 4.000 48,3500 4.000 48,3500 193.400
2023-12-04 AMPH Zhou Rong 3.514 59,5800 3.514 59,5800 209.364
2023-12-01 AMPH Zhou Rong 4.316 58,5800 4.316 58,5800 252.831
2023-06-15 AMPH Zhou Rong 5.000 51,7893 5.000 51,7893 258.946
2023-06-13 AMPH Zhou Rong 5.000 48,2400 5.000 48,2400 241.200
2023-05-18 AMPH Zhou Rong 10.000 44,2050 10.000 44,2050 442.050
2021-06-09 AMPH Zhou Rong 4.732 19,5800 4.732 19,5800 92.653
2021-06-08 AMPH Zhou Rong 8.180 19,3370 8.180 19,3370 158.177
2021-05-14 AMPH Zhou Rong 17.419 19,7178 17.419 19,7178 343.464
2021-05-13 AMPH Zhou Rong 700 19,5800 700 19,5800 13.706
2020-06-04 AMPH Zhou Rong 9.806 19,1900 9.806 19,1900 188.177
2020-06-03 AMPH Zhou Rong 13.163 18,8162 13.163 18,8162 247.678
2016-06-15 AMPH Zhou Rong 1.551 15,8503 1.551 15,8503 24.584
2015-12-16 AMPH Zhou Rong 772 14,2901 772 14,2901 11.032
2015-06-17 AMPH Zhou Rong 1.000 16,4800 1.000 16,4800 16.480

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Rong Zhou som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-03-18 2025-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
F - Taxes -1.967 137.497 -1,41 27,69 -54.466 3.807.292
2025-03-18 2025-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.222 139.464 -0,87 26,66 -32.579 3.718.110
2025-03-12 2025-03-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
A - Award 24.692 140.686 21,29
2025-03-10 2025-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.354 115.994 -1,15 28,32 -38.345 3.284.950
2025-03-06 2025-03-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.121 117.348 -0,95 27,62 -30.962 3.241.152
2024-12-16 2024-12-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -8.000 118.469 -6,33 45,23 -361.840 5.358.353
2024-12-16 2024-12-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 8.000 126.469 6,75 11,33 90.640 1.432.894
2024-12-16 2024-12-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -7.000 118.469 -5,58 44,42 -310.975 5.262.985
2024-12-16 2024-12-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.000 125.469 5,91 11,33 79.310 1.421.564
2024-11-13 2024-11-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -6.893 118.388 -5,50 48,88 -336.930 5.786.805
2024-11-13 2024-11-12 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.893 125.281 5,82 14,95 103.050 1.872.951
2024-09-17 2024-09-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
S - Sale -3.000 118.388 -2,47 48,26 -144.784 5.713.582
2024-09-17 2024-09-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
M - Exercise 3.000 121.388 2,53 14,95 44.850 1.814.751
2024-08-27 2024-08-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
S - Sale -4.000 118.388 -3,27 48,35 -193.400 5.724.060
2024-08-27 2024-08-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
M - Exercise 4.000 122.388 3,38 14,95 59.800 1.829.701
2024-03-19 2024-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.961 118.016 -1,63 43,05 -84.421 5.080.589
2024-03-19 2024-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
F - Taxes -2.355 119.977 -1,93 43,05 -101.383 5.165.010
2024-03-19 2024-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
F - Taxes -1.219 122.332 -0,99 43,05 -52.478 5.266.393
2024-03-08 2024-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
F - Taxes -1.390 123.551 -1,11 46,31 -64.371 5.721.647
2024-03-06 2024-03-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Srock
A - Award 12.521 124.941 11,14
2023-12-05 2023-12-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -3.514 112.420 -3,03 59,58 -209.364 6.697.984
2023-12-05 2023-12-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.514 115.934 3,13 16,19 56.892 1.876.971
2023-12-05 2023-12-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -4.316 112.420 -3,70 58,58 -252.831 6.585.564
2023-12-05 2023-12-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.316 116.736 3,84 14,40 62.150 1.680.998
2023-06-21 2023-06-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 9.651 112.341 9,40 11,33 109.346 1.272.824
2023-06-20 2023-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 1.171 102.690 1,15 16,19 18.958 1.662.551
2023-06-20 2023-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.631 101.519 4,78 14,95 69.233 1.517.709
2023-06-20 2023-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -5.000 96.888 -4,91 51,79 -258.946 5.017.762
2023-06-20 2023-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 13.575 101.888 15,37 14,40 195.480 1.467.187
2023-06-14 2023-06-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -5.000 88.313 -5,36 48,24 -241.200 4.260.219
2023-06-14 2023-06-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.000 93.313 5,66 14,40 72.000 1.343.707
2023-05-19 2023-05-18 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -10.000 87.598 -10,25 44,20 -442.050 3.872.270
2023-05-19 2023-05-18 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10.000 97.598 11,42 14,40 144.000 1.405.411
2023-03-20 2023-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.901 87.598 -2,12 36,29 -68.987 3.178.931
2023-03-20 2023-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.283 89.499 -2,49 37,60 -85.841 3.365.162
2023-03-17 2023-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.057 91.782 -2,19 36,84 -75.780 3.381.249
2023-03-08 2023-03-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 15.129 93.839 19,22
2022-03-18 2022-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.447 77.583 -3,06 34,18 -83.638 2.651.787
2022-03-18 2022-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -2.283 80.030 -2,77 34,22 -78.124 2.738.627
2022-03-17 2022-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 31.516 31.516
2022-03-17 2022-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.652 82.313 -1,97 34,74 -57.390 2.859.554
2022-03-17 2022-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 13.658 83.965 19,43
2022-03-01 2022-02-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -7.000 0 -100,00
2022-03-01 2022-02-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -13.246 70.307 -15,85 28,77 -381.087 2.022.732
2022-03-01 2022-02-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.000 83.553 9,14 10,93 76.510 913.234
2022-02-09 2022-02-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -7.000 7.000 -50,00
2022-02-09 2022-02-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.000 76.553 -8,38 26,77 -187.390 2.049.324
2022-02-09 2022-02-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.000 83.553 9,14 10,93 76.510 913.234
2022-01-11 2022-01-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -14.000 14.000 -50,00
2022-01-11 2022-01-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.251 76.553 -11,81 25,77 -264.156 1.972.679
2022-01-11 2022-01-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.677 86.804 -10,95 24,96 -266.528 2.166.871
2022-01-11 2022-01-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 14.000 97.481 16,77 10,93 153.020 1.065.467
2021-11-12 2021-11-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -7.813 0 -100,00
2021-11-12 2021-11-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.813 83.121 -8,59 21,67 -169.308 1.801.232
2021-11-12 2021-11-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.813 90.934 9,40 10,48 81.880 952.988
2021-08-04 2021-08-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -6.000 7.813 -43,44
2021-08-04 2021-08-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.123 83.121 -9,89 21,24 -193.734 1.765.141
2021-08-04 2021-08-02 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.000 92.244 6,96 10,48 62.880 966.717
2021-07-27 2021-07-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -6.000 13.813 -30,28
2021-07-27 2021-07-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.000 86.244 -6,50 20,87 -125.220 1.799.912
2021-07-27 2021-07-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.000 92.244 6,96 10,48 62.880 966.717
2021-07-22 2021-07-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -5.187 19.813 -20,75
2021-07-22 2021-07-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.187 86.244 -5,67 20,57 -106.697 1.774.039
2021-07-22 2021-07-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.187 91.431 6,01 10,48 54.360 958.197
2021-06-10 2021-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -4.732 86.244 -5,20 19,58 -92.653 1.688.658
2021-06-10 2021-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -8.180 0 -100,00
2021-06-10 2021-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -8.180 90.976 -8,25 19,34 -158.177 1.759.203
2021-06-10 2021-06-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 8.180 99.156 8,99 14,23 116.401 1.410.990
2021-05-17 2021-05-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -11.120 8.180 -57,62
2021-05-17 2021-05-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -17.419 89.966 -16,22 19,72 -343.464 1.773.932
2021-05-17 2021-05-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.120 107.385 11,55 14,23 158.238 1.528.089
2021-05-17 2021-05-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -700 19.300 -3,50
2021-05-17 2021-05-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -700 96.265 -0,72 19,58 -13.706 1.884.869
2021-05-17 2021-05-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 700 96.965 0,73 14,23 9.961 1.379.812
2021-03-18 2021-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 51.621 51.621
2021-03-18 2021-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 21.984 96.265 29,60
2021-03-18 2021-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -3.303 74.281 -4,26 18,44 -60.907 1.369.742
2021-03-17 2021-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.652 77.584 -2,08 19,15 -31.636 1.485.734
2020-06-05 2020-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -8.918 0 -100,00
2020-06-05 2020-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -9.806 79.236 -11,01 19,19 -188.177 1.520.539
2020-06-05 2020-06-04 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 8.918 89.042 11,13 11,41 101.754 1.015.969
2020-06-05 2020-06-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -11.082 8.918 -55,41
2020-06-05 2020-06-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -13.163 80.124 -14,11 18,82 -247.678 1.507.629
2020-06-05 2020-06-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.082 93.287 13,48 11,41 126.446 1.064.405
2020-03-18 2020-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -992 80.891 -1,21 14,50 -14.384 1.172.920
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 61.822 61.822
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 26.400 81.883 47,58
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.020 55.483 -1,81 13,03 -13.291 722.943
2020-03-17 2020-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.653 56.503 -2,84 14,19 -23.456 801.778
2019-06-17 2019-06-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -204 58.156 -0,35 19,82 -4.043 1.152.652
2019-05-07 2019-05-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -9.600 0 -100,00
2019-05-07 2019-05-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.600 57.107 -14,39 22,76 -218.496 1.299.755
2019-05-07 2019-05-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 9.600 66.707 16,81 20,26 194.496 1.351.484
2019-03-28 2019-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -814 57.107 -1,41 20,54 -16.720 1.172.978
2019-03-18 2019-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.510 57.921 -2,54 20,23 -30.547 1.171.742
2019-03-18 2019-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.553 59.431 -2,55 20,23 -31.417 1.202.289
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 22.541 22.541
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.179 60.984 -1,90 20,23 -23.851 1.233.706
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 10.133 62.163 19,48
2019-03-04 2019-03-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -3.200 6.400 -33,33
2019-03-04 2019-03-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.200 52.030 -5,79 25,00 -80.000 1.300.750
2019-03-04 2019-03-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.200 55.230 6,15 20,26 64.832 1.118.960
2019-03-04 2019-02-05 4/A AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -3.200 9.600 -25,00
2019-02-07 2019-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -3.200 12.800 -20,00
2019-02-07 2019-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -4.289 52.030 -7,62 23,00 -98.647 1.196.690
2019-02-07 2019-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.200 56.319 6,02 20,26 64.832 1.141.023
2018-12-06 2018-12-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.089 53.119 -2,01 22,00 -23.958 1.168.618
2018-11-13 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.089 53.303 -2,00 21,00 -22.869 1.119.363
2018-11-13 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.084 54.392 -1,95 20,00 -21.680 1.087.840
2018-06-18 2018-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -134 55.476 -0,24 16,88 -2.262 936.435
2018-03-28 2018-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -535 54.434 -0,97 18,61 -9.956 1.013.017
2018-03-20 2018-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -969 54.969 -1,73 19,91 -19.293 1.094.433
2018-03-20 2018-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.128 55.938 -1,98 19,91 -22.458 1.113.726
2018-03-16 2018-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 20.827 20.827
2018-03-16 2018-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 8.969 57.066 18,65
2017-06-16 2017-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -146 48.096 -0,30 16,18 -2.362 778.193
2017-03-28 2017-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -568 46.972 -1,19 13,76 -7.816 646.335
2017-03-20 2017-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.248 47.540 -2,56 13,75 -17.160 653.675
2017-03-20 2017-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 29.424 29.424
2017-03-20 2017-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 11.797 48.788 31,89
2016-12-07 2016-12-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -61 36.991 -0,16 20,70 -1.262 765.547
2016-06-17 2016-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -146 36.991 -0,39 15,76 -2.301 582.978
2016-06-17 2016-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1.551 37.137 -4,01 15,85 -24.584 588.633
2016-03-29 2016-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -568 37.137 -1,51 11,96 -6.793 444.159
2016-03-21 2016-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 34.438 34.438
2016-03-21 2016-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 11.473 37.705 43,74
2015-12-17 2015-12-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -772 25.460 -2,94 14,29 -11.032 363.826
2015-06-19 2015-06-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -1.000 26.232 -3,67 16,48 -16.480 432.303
2015-06-17 2015-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 4.685 4.685
2015-06-17 2015-06-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 1.544 27.232 6,01
2015-06-17 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
156.044
2015-06-17 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
230.024
2015-06-17 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
135.356
2015-06-17 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
156.044
2015-06-17 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
230.024
2015-06-17 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
135.356
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)